-
10:53:47 AM
Sign in with email
Forgot your password?
Register with email
Account Verification

CDNA Stock News

08/02/22 7:01 AM
Nasdaq : CDNA
CareDx Launches Personalized AlloHome Patient Monitoring Solution to Augment Pre- and Post-Transplant Care
CareDx, Inc.– The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers– today announced the availability of AlloHome™, a pan-organ patient monitoring solution that extends care into a patient’ s home by capturing a range of...
RHEA-AI
neutral
07/28/22 7:01 AM
Nasdaq : CDNA
CareDx Demonstrates Industry-Leading Commitment to Advancing Transplant Innovation as Distinguished Founder’s Circle Sponsor for the 2022 American Society of Transplant Surgeons Symposium
CareDx, Inc.– The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers– today announced its leading participation and top spot, for the third year in a row, as a Distinguished Founder’ s Circle Sponsor for the 2022 American...
RHEA-AI
positive
06/02/22 7:01 AM
Nasdaq : CDNA
CareDx Leads Transplant Innovation with AiKidney, an AI Clinical Decision Support Tool for Predicting Allograft Rejection Risk
CareDx, Inc.– The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers– today announced that it plans to expand its growing multimodality portfolio with AiKidney™, a new allograft risk assessment clinical decision support...
RHEA-AI
neutral
06/01/22 7:01 AM
Nasdaq : CDNA
CareDx Innovation Showcased in Record-Breaking Number of Scientific Abstracts with Over 50 Presented at 2022 Transplant Congress
CareDx, Inc.– The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers– today announced a leading presence at the 2022 American Transplant Congress with over 50 oral and scientific poster presentations.
RHEA-AI
neutral